Quadrant Capital Group’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
Other funds holding HALO
VCM
VPM
Quadrant Capital Group's HALO Position: Q1 2026 in Review
Quadrant Capital Group increased its Halozyme (HALO) stake by 5.2% in Q1 2026, buying an estimated $30.1K and bringing the position to 8,623 shares worth $557K. The position accounts for 0.02% of the portfolio, ranked #859.
Quadrant Capital Group first reported a position in HALO in Q4 2015 and has held it in 27 quarters since. The position peaked at $624K in Q3 2025. 634 funds tracked by Wall St. Rank hold HALO as of Q1 2026.
- Quadrant Capital Group held 8,623 shares of Halozyme worth $557K as of Q1 2026.
- Quadrant Capital Group bought 427 Halozyme shares in Q1 2026, an estimated $30.1K.
- Halozyme made up 0.02% of Quadrant Capital Group's portfolio in Q1 2026, its #859 holding.
- Quadrant Capital Group first reported a position in Halozyme in Q4 2015 and has held it in 27 quarters since.
- Quadrant Capital Group's Halozyme position peaked at $624K in Q3 2025.
- 634 funds tracked by Wall St. Rank held Halozyme as of Q1 2026.
Based on Quadrant Capital Group's 13F filing for Q1 2026, filed 11 May 2026.